top of page

Search

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

agbiopro

Aug 3, 20200 min read

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Comments

bottom of page